115 related articles for article (PubMed ID: 1431933)
1. A bioassay for inhibition of serotonin release from bovine platelets.
Marles RJ; Kaminski J; Arnason JT; Pazos-Sanou L; Heptinstall S; Fischer NH; Crompton CW; Kindack DG; Awang DV
J Nat Prod; 1992 Aug; 55(8):1044-56. PubMed ID: 1431933
[TBL] [Abstract][Full Text] [Related]
2. Parthenolide content and bioactivity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.). Estimation of commercial and authenticated feverfew products.
Heptinstall S; Awang DV; Dawson BA; Kindack D; Knight DW; May J
J Pharm Pharmacol; 1992 May; 44(5):391-5. PubMed ID: 1359053
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effects of an extract of feverfew and parthenolide, a component of feverfew, on human platelet activity in-vitro.
Groenewegen WA; Heptinstall S
J Pharm Pharmacol; 1990 Aug; 42(8):553-7. PubMed ID: 1981582
[TBL] [Abstract][Full Text] [Related]
4. Extracts of feverfew inhibit granule secretion in blood platelets and polymorphonuclear leucocytes.
Heptinstall S; White A; Williamson L; Mitchell JR
Lancet; 1985 May; 1(8437):1071-4. PubMed ID: 2860288
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological activity of feverfew (Tanacetum parthenium (L.) Schultz-Bip.): assessment by inhibition of human polymorphonuclear leukocyte chemiluminescence in-vitro.
Brown AM; Edwards CM; Davey MR; Power JB; Lowe KC
J Pharm Pharmacol; 1997 May; 49(5):558-61. PubMed ID: 9178194
[TBL] [Abstract][Full Text] [Related]
6. Three newly identified lipophilic flavonoids in Tanacetum parthenium supercritical fluid extract penetrating the Blood-Brain Barrier.
Végh K; Riethmüller E; Hosszú L; Darcsi A; Müller J; Alberti Á; Tóth A; Béni S; Könczöl Á; Balogh GT; Kéry Á
J Pharm Biomed Anal; 2018 Feb; 149():488-493. PubMed ID: 29182998
[TBL] [Abstract][Full Text] [Related]
7. 5-Hydroxytryptamine-inhibiting property of Feverfew: role of parthenolide content.
Mittra S; Datta A; Singh SK; Singh A
Acta Pharmacol Sin; 2000 Dec; 21(12):1106-14. PubMed ID: 11603284
[TBL] [Abstract][Full Text] [Related]
8. Intra-specific variability of feverfew: correlations between parthenolide, morphological traits and seed origin.
Cutlan AR; Bonilla LE; Simon JE; Erwin JE
Planta Med; 2000 Oct; 66(7):612-7. PubMed ID: 11105564
[TBL] [Abstract][Full Text] [Related]
9. Sulfhydryl/disulfide-status of blood platelets--a target for pharmacological intervention?
Till U; Bergmann I; Breddin K; Heptinstall S; Lösche W; Mazurov A; Pescarmona G
Prog Clin Biol Res; 1989; 301():341-5. PubMed ID: 2678129
[No Abstract] [Full Text] [Related]
10. Effects of an extract of feverfew (Tanacetum parthenium) on arachidonic acid metabolism in human blood platelets.
Loesche W; Groenewegen WA; Krause S; Spangenberg P; Heptinstall S
Biomed Biochim Acta; 1988; 47(10-11):S241-3. PubMed ID: 3248111
[TBL] [Abstract][Full Text] [Related]
11. Attempts of chemical standardizing of Chrysanthemum parthenium as a prospective antimigraine drug.
Gromek D; Kisiel W; Stojakowska A; Kohlmünzer S
Pol J Pharmacol Pharm; 1991; 43(3):213-7. PubMed ID: 1961694
[TBL] [Abstract][Full Text] [Related]
12. Biosynthesis and localization of parthenolide in glandular trichomes of feverfew (Tanacetum parthenium L. Schulz Bip.).
Majdi M; Liu Q; Karimzadeh G; Malboobi MA; Beekwilder J; Cankar K; Vos Rd; Todorović S; Simonović A; Bouwmeester H
Phytochemistry; 2011 Oct; 72(14-15):1739-50. PubMed ID: 21620424
[TBL] [Abstract][Full Text] [Related]
13. Contact allergy to parthenolide in Tanacetum parthenium (L.) Schulz-Bip. (feverfew, Asteraceae) and cross-reactions to related sesquiterpene lactone containing Compositae species.
Hausen BM; Osmundsen PE
Acta Derm Venereol; 1983; 63(4):308-14. PubMed ID: 6195862
[TBL] [Abstract][Full Text] [Related]
14. Compounds extracted from feverfew that have anti-secretory activity contain an alpha-methylene butyrolactone unit.
Groenewegen WA; Knight DW; Heptinstall S
J Pharm Pharmacol; 1986 Sep; 38(9):709-12. PubMed ID: 2877077
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of 5-lipoxygenase and cyclo-oxygenase in leukocytes by feverfew. Involvement of sesquiterpene lactones and other components.
Sumner H; Salan U; Knight DW; Hoult JR
Biochem Pharmacol; 1992 Jun; 43(11):2313-20. PubMed ID: 1319159
[TBL] [Abstract][Full Text] [Related]
16. [Studies on the antimigraine action of Feverfew (Tanacetum parthenium (L.) Sch. Bip.)].
Studzińska-Sroka E; Znajdek-Awizeń P; Gawron-Gzella A
Wiad Lek; 2013; 66(2 Pt 2):195-9. PubMed ID: 25775817
[TBL] [Abstract][Full Text] [Related]
17. Effects of compounds extracted from Tanacetum microphyllum on arachidonic acid metabolism in cellular systems.
Silván AM; Abad MJ; Bermejo P; Villar A
Planta Med; 1998 Apr; 64(3):200-3. PubMed ID: 9581513
[TBL] [Abstract][Full Text] [Related]
18. The Anti-Serotonin Effect of Parthenolide Derivatives and Standardised Extract from the Leaves of
Nawrot J; Napierała M; Kaczerowska-Pietrzak K; Florek E; Gornowicz-Porowska J; Pelant E; Nowak G
Molecules; 2019 Nov; 24(22):. PubMed ID: 31731603
[TBL] [Abstract][Full Text] [Related]
19. Feverfew extracts and the sesquiterpene lactone parthenolide inhibit intercellular adhesion molecule-1 expression in human synovial fibroblasts.
Piela-Smith TH; Liu X
Cell Immunol; 2001 May; 209(2):89-96. PubMed ID: 11446741
[TBL] [Abstract][Full Text] [Related]
20. Extracts of feverfew may inhibit platelet behaviour via neutralization of sulphydryl groups.
Heptinstall S; Groenewegen WA; Spangenberg P; Loesche W
J Pharm Pharmacol; 1987 Jun; 39(6):459-65. PubMed ID: 2886604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
